American Cancer Society.Prostate cancer screening recommendations. Available at: http://www.cancer.org. Accessed March 2, 2005.
2.
BarryM.J.. Clinical practice: prostate-specific-antigen testing for early diagnosis of prostate cancer.N Engl J Med.2001; 344: 1373–1377.
3.
BrawleyO.W.. Prostate cancer screening: clinical applications and challenges.Urol Oncol.2004; 22: 353–357.
4.
BurackR.C., WoodDPJr. Screening for prostate cancer: the challenge of promoting informed decision making in the absence of definitive evidence of effectiveness.Med Clin North Am.1999; 83: 1423–1442.
5.
KatzA., SislerJ.J.. What's a doctor to do? Helping patients decide about prostate cancer screening.Can Fam Physician.2004; 50: 14–16, 22-14.
6.
US Preventive Services Task Force.Screening for prostate cancer: recommendation and rationale.Ann Intern Med.2002; 137: 915–916.
7.
ChanE.C., SulmasyD.P.. What should men know about prostate-specific antigen screening before giving informed consent?Am J Med.1998; 105: 266–274.
8.
KimS.P., KnightS.J., TomoriC.. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.Cancer Invest.2001; 19: 684–691.
9.
O'DellK.J., VolkR.J., CassA.R.. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?J Fam Pract.1999; 48: 682–688.
10.
ChanE.C., VernonS.W., O'DonnellF.T.. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?Am J Public Health.2003; 93: 779–785.
11.
LevinsonW., KaoA., KubyA.. Not all patients want to participate in decision making: a national study of public preferences.J Gen Intern Med.2005; 20: 531–535.
12.
DavisT.C., CrouchM.A., LongS.W.. Rapid assessment of literacy levels of adult primary care patients.Fam Med.1991; 23: 433–435.
13.
DavisT.C., KennenE.M., GazmararianJ.A.. Literacy testing in health care research. In: SchwartzbergJ.G., VanGeestJ.B., WangC.C., eds. Understanding Health Literacy: Implications for Medicine and Public Health.Chicago, Ill: American Medical Assoc;2005: 157–179.
14.
FedermanD.G., GoyalS., KaminaA.. Informed consent for PSA screening: does it happen?Eff Clin Pract.1999; 2: 152–157.
15.
BarryM.J.. Health decision aids to facilitate shared decision making in office practice.Ann Intern Med.2002; 136: 127–135.
16.
DeberR.B.. Shared decision making in the real world.J Gen Intern Med.1996; 11: 377–378.
17.
FloodA.B., WennbergJ.E., NeaseRFJr. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.J Gen Intern Med.1996; 11: 342–349.
18.
FroschD.L., KaplanR.M., FelittiV.. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test.J Gen Intern Med.2001; 16: 391–398.
19.
FroschD.L., KaplanR.M., FelittiV.J.. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test.J General Intern Med.2003; 18: 781–787.
20.
SheridanS.L., FelixK., PignoneM.P.. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.Patient Educ Couns.2004; 54: 345–351.
21.
VolkR.J., CassA.R., SpannS.J.. A randomized controlled trial of shared decision making for prostate cancer screening.Arch Fam Med.1999; 8: 333–340.
22.
VolkR.J., SpannS.J., CassA.R.. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up.Ann Fam Med.2003; 1: 22–28.
23.
GattellariM., WardJ.E.. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.J Med Screen.2003; 10: 27–39.
24.
SchapiraM.M., VanRuiswykJ.. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests.J Fam Pract.2000; 49: 418–424.
25.
TaylorK.L., TurnerR.O., DavisJL3rd. Improving knowledge of the prostate cancer screening dilemma among African American men: an academic-community partnership in Washington, DC.Public Health Rep.2001; 116: 590–598.